The global rat and mouse model market, valued at $1.46 billion in 2023, is expected to reach $3.10 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.10% from 2024 to 2034. This growth is driven by increasing research and development activities in pharmaceutical and healthcare sectors.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5212
Key Market Insights
- Regional Insights
- North America dominated the market with a 49.8% share in 2023.
- The Asia Pacific region is projected to experience significant growth during the forecast period.
- Segment Analysis
- By Model and Services: The model segment held the largest market share in 2023, while the services segment is expected to grow at the fastest CAGR from 2024 to 2034.
- By Application: The cancer segment was the largest market segment in 2023. Meanwhile, the genetic diseases segment is predicted to grow at the highest rate during the forecast period.
- By End-Use: Pharmaceutical and biotechnology companies held the largest share of the market in 2023. However, contract research and manufacturing organizations are anticipated to grow at the fastest rate in the coming years.
Importance of Rat and Mouse Models in Medical Research
Rat and mouse models are essential for preclinical research, offering insights into various biological processes and disease mechanisms. While mice have historically been the preferred model, rats are gaining popularity in specialized fields like neurology due to their unique advantages. Advances in gene-editing tools have expanded the capabilities of creating disease models in these species, driving further market growth.
Role of AI in Enhancing Rat and Mouse Models
Artificial intelligence (AI) and machine learning (ML) are transforming preclinical studies involving rat and mouse models by:
- Analyzing complex datasets.
- Optimizing experimental design.
- Predicting outcomes.
Integrating AI with animal model data and clinical human data enhances the relevance of findings, bridging the gap between preclinical and clinical research. For instance, in June 2024, researchers created a virtual rat with an AI brain to simulate real rats’ movements, yielding new insights into brain function that could revolutionize neurology and robotics.
Notable Companies in the Rat and Mouse Model Market
Key players in this market include:
- Charles River Laboratories
- Ozgene Pty Ltd
- Cyagen
- Inotiv
- The Jackson Laboratory
- genOway
- Taconic Biosciences, Inc.
- Kind Lab
- Biomedical Research Models (Biomere)
- Janvier Labs
- Hera Biolabs
- SMOC (Shanghai Model Organisms Center)
- The University of Texas Health Science Center
Recent Innovations
- The University of Texas Health Science Center: In July 2024, researchers developed a humanized mouse model with a human-like immune system and gut microbiota, which can generate specific antibody responses. This innovation is expected to advance immunotherapy and disease model research.
- SMOC (Shanghai Model Organisms Center): In January 2024, SMOC launched the U-HuDTMbase®, a comprehensive resource library of therapeutic target-humanized mouse models, covering over 600 models across various fields, including cancer, metabolism, immunology, and inflammation.
Future Prospects
The rat and mouse model market is poised for continued growth due to ongoing research across diverse sectors like healthcare, pharmaceuticals, biotechnology, and cosmetics. Animal studies play a critical role in understanding disease mechanisms and developing new treatments, despite ethical concerns surrounding their use.
In 2022, 2.76 million scientific operations involving live animals were conducted in the UK, with 1.51 million for experimental purposes and 1.25 million (45% of all procedures) for creating and breeding genetically altered (GA) animals.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/rat-and-mouse-model-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5212
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare